Impact of Unrestricted Drug Use on Psychiatric and Behavioral Disorders: Exploring Mental Health Effects in the United States

Authors

  • Excel Onajite Ernest-Okonofua Department of Public Health, Igbinedion University, Nigeria
  • Franklin ibadin Department of Public Health, Igbinedion University, Nigeria
  • Aminu Sufu Mahmud Department of Mental Health, University of South Alabama, United States
  • Ifeoma Theodora Abengowe Department of Public Health, Igbinedion University, Nigeria
  • Ogheneyemarho Great Oyiborhoro Department of Public Health, Igbinedion University, Nigeria

DOI:

https://doi.org/10.54536/ajmsi.v4i2.4036

Keywords:

Drug Accessibility, Integrated Care, Mental Health Disorders, Public Awareness, Substance Abuse

Abstract

Illicit substance abuse in the United States remains a public health concern as a survey shows that 59% of the population aged 12 or older use illicit substances in a year. Legal highs such as marijuana, opioids, synthetic cannabis, and other substances are responsible for high addiction rates and mental illness. Issues like legalization, online drugs, and polydrug use only make these issues worse. Special groups are particularly vulnerable to getting treatment hence making the effects of substance use not only societal but individual as well. This research aims to establish the correlation between the use of drugs without prescription and mental illness. It also details how the availability of drugs affects mental health and looks at how to prevent or treat the problem effectively. A cross-sectional survey design was employed, and the quantitative data collected from 378 participants was analysed. Data was collected with the help of online questionnaires, including participants’ background information, their drug-taking behaviour, and psychiatric disorders. Descriptive analysis was performed utilising the SPSS statistical tool to compare the data sets. The study shows a positive correlation between substance use and the presence of psychiatric disorders, including anxiety, depression and psychosis. The participants well understand these links and there was an appreciation of early intervention and integrated care models of treatment. However, there are still gaps in the treatment, especially among the marginalised groups of society. The study highlights the need to increase awareness of the disease, improve treatment access, and to deliver specific interventions. Approaches that address education, equal access to treatment, and stigma are essential interventions for addressing the two risks posed by substance use and related mental health effects.

Downloads

Download data is not yet available.

References

Alam, M. K. (2020). A systematic qualitative case study: Questions, data collection, NVivo analysis and saturation. Qualitative Research in Organizations and Management: An International Journal, 16(1), 1–31. https://doi.org/10.1108/QROM-09-2019-1825

Azofeifa-Ujueta, A. (2023). Assessing and characterizing marijuana use disorders (DSM-5)—National survey on drug use and health, United States, 2020. Western Michigan University.

Azofeifa, A. (2019). Driving under the influence of marijuana and illicit drugs among persons aged ≥ 16 years—United States, 2018. MMWR. Morbidity and Mortality Weekly Report, 68.

Alegría, M., & Frank, R. G. (2024). Policymakers should prioritize funding for programs that combine mental health and substance abuse treatment. Google Scholar.

Ali, A. M., Alkhamees, A. A., Hori, H., Kim, Y., & Kunugi, H. (2021). The Depression Anxiety Stress Scale 21: Development and validation of the Depression Anxiety Stress Scale 8-item in psychiatric patients and the general public for easier mental health measurement in a post COVID-19 world. International Journal of Environmental Research and Public Health, 18(19), 10142. https://doi.org/10.3390/ijerph181910142

Aljarallah, N. A., Almuqbil, M., Alshehri, S., Khormi, A. M. S., AlReshaidan, R. M., Alomran, F. H., Fawzan Alomar, N., Alshahrani, F. F., Alshammari, M. S., Alsanie, W. F., Alhomrani, M., Alamri, A. S., & Asdaq, S. M. B. (2023). Satisfaction of patients with health care services in tertiary care facilities of Riyadh, Saudi Arabia: A cross-sectional approach. Frontiers in Public Health, 10. https://doi.org/10.3389/fpubh.2022.1077147

Amaro, H., Sanchez, M., Bautista, T., & Cox, R. (2021). Social vulnerabilities for substance use: Stressors, socially toxic environments, and discrimination and racism. Neuropharmacology, 188, 108518. https://doi.org/10.1016/j.neuropharm.2021.108518

Bercaw, L. E., Levinson, A., Fletcher, D., Shuman, S. B., Hughes, S., Peddada, S., & Walsh, E. G. (2022). Assessing disparities in Medicaid home- and community-based services: A systematic review. Journal of Aging & Social Policy, 1–20. https://doi.org/10.1080/08959420.2022.2081424

Casella, G., & Berger, R. (2024). Statistical inference. Google Books.

Crummy, E. A., O’Neal, T. J., Baskin, B. M., & Ferguson, S. M. (2020). One is not enough: Understanding and modeling polysubstance use. Frontiers in Neuroscience, 14, 569.

Drew, J. M., & Martin, S. (2021). A national study of police mental health in the USA: Stigma, mental health and help-seeking behaviors. Journal of Police and Criminal Psychology, 36(2), 295–306.

Drupp, M. A., Kornek, U., Meya, J. N., & Sager, L. (2021). Inequality and the environment: The economics of a two-headed hydra. Econstor. http://hdl.handle.net/10419/248992

Hayes, A. F. (2020). Statistical methods for communication science. Routledge. https://doi.org/10.4324/9781410613707

Jemberie, W. B., Stewart Williams, J., Eriksson, M., Grönlund, A. S., Ng, N., Blom Nilsson, M., Padyab, M., Priest, K. C., Sandlund, M., Snellman, F., McCarty, D., & Lundgren, L. M. (2020). Substance use disorders and COVID-19: Multi-faceted problems which require multi-pronged solutions. Frontiers in Psychiatry, 11. https://doi.org/10.3389/fpsyt.2020.00714

Larkin Jr, P. J., & Madras, B. K. (2019). Opioids, overdoses, and cannabis: Is marijuana an effective therapeutic response to the opioid abuse epidemic? Georgetown Journal of Law & Public Policy, 17, 555.

MI Naples. (2021, March 8). About. HeinOnline. Retrieved from https://heinonline.org/HOL/LandingPage?handle=hein.journals/rutjulp19&div=15&id=&page=

Rahman, M. M. (2023). Sample size determination for survey research and non-probability sampling techniques: A review and set of recommendations. Journal of Entrepreneurship, Business and Economics. Retrieved from https://www.scientificia.com/index.php/JEBE/article/view/201

McCabe, S. E., West, B. T., Jutkiewicz, E. M., & Boyd, C. J. (2017). Multiple DSM-5 substance use disorders: A national study of US adults. Human Psychopharmacology: Clinical and Experimental, 32(5), e2625. https://doi.org/10.1002/hup.2625

McCann, J. D. (2020). Do no good: How controlled substance regulations prohibit the use of telemedicine to provide medication-assisted therapy for opioid use disorder. Tulsa Law Review, 56, 313.

McCollister, K., Yang, X., Sayed, B., French, M. T., Leff, J. A., & Schackman, B. R. (2017). Monetary conversion factors for economic evaluations of substance use disorders. Journal of Substance Abuse Treatment, 81, 25–34. https://doi.org/10.1016/j.jsat.2017.07.001

Mongelli, F., Georgakopoulos, P., & Pato, M. T. (2020). Challenges and opportunities to meet the mental health needs of underserved and disenfranchised populations in the United States. Focus, 18(1), 16–24. https://doi.org/10.1176/appi.focus.20190035

Na, B., Jiwon, J., & Park. (2024). APA PsycNet. Retrieved from https://psycnet.apa.org/fulltext/2022-40012-001.html

Nawi, A. M., Ismail, R., Ibrahim, F., Hassan, M. R., Manaf, M. R. A., Amit, N., Ibrahim, N., & Shafurdin, N. S. (2021). Risk and protective factors of drug abuse among adolescents: A systematic review. BMC Public Health, 21(1). https://doi.org/10.1186/s12889-021-11906-2

Okagbue, H. I., Oguntunde, P. E., Obasi, E. C. M., & Akhmetshin, E. M. (2021). Trends and usage pattern of SPSS and Minitab software in scientific research. Journal of Physics: Conference Series, 1734(1), 012017. https://doi.org/10.1088/1742-6596/1734/1/012017

Pallant, J. (2020). SPSS survival manual.

Preuss, C. V., Kalava, A., & King, K. C. (2019). Prescription of controlled substances: Benefits and risks.

Price, A. (2020). Online gambling in the midst of COVID-19: A nexus of mental health concerns, substance use, and financial stress. International Journal of Mental Health and Addiction, 20(1). https://doi.org/10.1007/s11469-020-00366-1

Reilly, M. (2021). Health disparities and access to healthcare in rural vs. urban areas. Theory in Action, 14(2), 6–27. https://doi.org/10.3798/tia.1937-0237.2109

Salmanzadeh, H., Ahmadi-Soleimani, S. M., Pachenari, N., Azadi, M., Halliwell, R. F., Rubino, T., & Azizi, H. (2020). Adolescent drug exposure: A review of evidence for the development of persistent changes in brain function. Brain Research Bulletin, 156(1), 105–117. https://doi.org/10.1016/j.brainresbull.2020.01.007

Thapar, A., Eyre, O., Patel, V., & Brent, D. (2022). Depression in young people. The Lancet, 400(10352), 617–631. https://doi.org/10.1016/s0140-6736(22)01012-1

Van. (2023). Tackling addiction with integrated care. Open Journal of Therapy and Rehabilitation, 11(3), 122–147. https://doi.org/10.4236/ojtr.2023.113010

World Health Organization. (2020). Operational framework for primary health care: Transforming vision into action. Retrieved from https://iris.who.int/bitstream/handle/10665/337641/9789240017832-eng.pdf

Downloads

Published

2025-07-05

How to Cite

Onajite Ernest-Okonofua, E., ibadin, F., Sufu Mahmud, A., Theodora Abengowe, I., & Great Oyiborhoro, O. (2025). Impact of Unrestricted Drug Use on Psychiatric and Behavioral Disorders: Exploring Mental Health Effects in the United States. American Journal of Medical Science and Innovation, 4(2), 1–8. https://doi.org/10.54536/ajmsi.v4i2.4036